Status:
NOT_YET_RECRUITING
Folic Acid Supplementation to Reduce Anemia in Extremely Preterm Infants
Lead Sponsor:
University of Calgary
Conditions:
Extreme Prematurity
Anemia of Prematurity
Eligibility:
All Genders
Phase:
NA
Brief Summary
Anemia of Prematurity (AOP) is very common in extremely preterm infants and often leads to blood transfusions. Folic acid, essential for growth and DNA synthesis, is deficient in premature infants. De...
Detailed Description
Anemia of prematurity (AOP) affects nearly all extremely preterm or extremely low birthweight (ELBW; birthweight \<1000 g) infants. AOP's development involves various factors such as exacerbation of n...
Eligibility Criteria
Inclusion
- Infants born at \<29 weeks of gestational age admitted to Foothill Medical Centre.
- Postnatal age 14 days.
- On minimum enteral feeding of 100 mL/kg/day
Exclusion
- Infants with major congenital or chromosomal anomalies
- Infants with ongoing pulmonary or gastroenterology hemorrhage by 14 days of life.
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2028
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06220461
Start Date
June 1 2024
End Date
July 31 2028
Last Update
May 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Foothills Medical Centre
Calgary, Alberta, Canada, T2N2T9